These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer. McAndrews KM; Chen Y; Darpolor JK; Zheng X; Yang S; Carstens JL; Li B; Wang H; Miyake T; Correa de Sampaio P; Kirtley ML; Natale M; Wu CC; Sugimoto H; LeBleu VS; Kalluri R Cancer Discov; 2022 Jun; 12(6):1580-1597. PubMed ID: 35348629 [TBL] [Abstract][Full Text] [Related]
4. GPR68, a proton-sensing GPCR, mediates interaction of cancer-associated fibroblasts and cancer cells. Wiley SZ; Sriram K; Liang W; Chang SE; French R; McCann T; Sicklick J; Nishihara H; Lowy AM; Insel PA FASEB J; 2018 Mar; 32(3):1170-1183. PubMed ID: 29092903 [TBL] [Abstract][Full Text] [Related]
5. Vimentin Expression in Tumor Microenvironment Predicts Survival in Pancreatic Ductal Adenocarcinoma: Heterogeneity in Fibroblast Population. Maehira H; Miyake T; Iida H; Tokuda A; Mori H; Yasukawa D; Mukaisho KI; Shimizu T; Tani M Ann Surg Oncol; 2019 Dec; 26(13):4791-4804. PubMed ID: 31583548 [TBL] [Abstract][Full Text] [Related]
6. Schwann cells regulate tumor cells and cancer-associated fibroblasts in the pancreatic ductal adenocarcinoma microenvironment. Xue M; Zhu Y; Jiang Y; Han L; Shi M; Su R; Wang L; Xiong C; Wang C; Wang T; Deng S; Wu D; Cao Y; Dong L; Bai F; Zhao S; Deng X; Peng C; Li H; Chen J; Shen B; Jiang L; Chen H Nat Commun; 2023 Jul; 14(1):4600. PubMed ID: 37524695 [TBL] [Abstract][Full Text] [Related]
7. Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma. Zhang A; Qian Y; Ye Z; Chen H; Xie H; Zhou L; Shen Y; Zheng S Cancer Med; 2017 Feb; 6(2):463-470. PubMed ID: 28097809 [TBL] [Abstract][Full Text] [Related]
8. Inter- and intra-tumoural heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma. Neuzillet C; Tijeras-Raballand A; Ragulan C; Cros J; Patil Y; Martinet M; Erkan M; Kleeff J; Wilson J; Apte M; Tosolini M; Wilson AS; Delvecchio FR; Bousquet C; Paradis V; Hammel P; Sadanandam A; Kocher HM J Pathol; 2019 May; 248(1):51-65. PubMed ID: 30575030 [TBL] [Abstract][Full Text] [Related]
9. Desmoplastic Crosstalk in Pancreatic Ductal Adenocarcinoma Is Reflected by Different Responses of Panc-1, MIAPaCa-2, PaTu-8902, and CAPAN-2 Cell Lines to Cancer-associated/Normal Fibroblasts. Novák Š; Kolář M; Szabó A; Vernerová Z; Lacina L; Strnad H; Šáchová J; Hradilová M; Havránek J; Španko M; Čoma M; Urban L; Kaňuchová M; Melegová N; Gürlich R; Dvořák J; Smetana K; Gál P; Szabo P Cancer Genomics Proteomics; 2021; 18(3):221-243. PubMed ID: 33893076 [TBL] [Abstract][Full Text] [Related]
10. Interleukin 1α sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts. Tjomsland V; Spångeus A; Välilä J; Sandström P; Borch K; Druid H; Falkmer S; Falkmer U; Messmer D; Larsson M Neoplasia; 2011 Aug; 13(8):664-75. PubMed ID: 21847358 [TBL] [Abstract][Full Text] [Related]
11. Pancreatic Fibroblasts Stimulate the Motility of Pancreatic Cancer Cells through IGF1/IGF1R Signaling under Hypoxia. Hirakawa T; Yashiro M; Doi Y; Kinoshita H; Morisaki T; Fukuoka T; Hasegawa T; Kimura K; Amano R; Hirakawa K PLoS One; 2016; 11(8):e0159912. PubMed ID: 27487118 [TBL] [Abstract][Full Text] [Related]
12. Opportunities and delusions regarding drug delivery targeting pancreatic cancer-associated fibroblasts. Liu H; Shi Y; Qian F Adv Drug Deliv Rev; 2021 May; 172():37-51. PubMed ID: 33705881 [TBL] [Abstract][Full Text] [Related]
13. Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors. Lai TY; Chiang TC; Lee CY; Kuo TC; Wu CH; Chen YI; Hu CM; Maskey M; Tang SC; Jeng YM; Tien YW; Lee EYP; Lee WH Br J Cancer; 2024 Apr; 130(7):1096-1108. PubMed ID: 38341509 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism. Sun X; He X; Zhang Y; Hosaka K; Andersson P; Wu J; Wu J; Jing X; Du Q; Hui X; Ding B; Guo Z; Hong A; Liu X; Wang Y; Ji Q; Beyaert R; Yang Y; Li Q; Cao Y Gut; 2022 Jan; 71(1):129-147. PubMed ID: 33568427 [TBL] [Abstract][Full Text] [Related]
16. Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer. Yamamoto K; Tateishi K; Kudo Y; Hoshikawa M; Tanaka M; Nakatsuka T; Fujiwara H; Miyabayashi K; Takahashi R; Tanaka Y; Ijichi H; Nakai Y; Isayama H; Morishita Y; Aoki T; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M; Koike K Oncotarget; 2016 Sep; 7(38):61469-61484. PubMed ID: 27528027 [TBL] [Abstract][Full Text] [Related]
17. Targeting Aggressive Fibroblasts to Enhance the Treatment of Pancreatic Cancer. Yu Y; Schuck K; Friess H; Kong B Expert Opin Ther Targets; 2021 Jan; 25(1):5-13. PubMed ID: 33246383 [TBL] [Abstract][Full Text] [Related]
18. Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function. Begum A; McMillan RH; Chang YT; Penchev VR; Rajeshkumar NV; Maitra A; Goggins MG; Eshelman JR; Wolfgang CL; Rasheed ZA; Matsui W Pancreas; 2019 Mar; 48(3):329-334. PubMed ID: 30747824 [TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts reprogram cysteine metabolism to increase tumor resistance to ferroptosis in pancreatic cancer. Zhu Y; Fang S; Fan B; Xu K; Xu L; Wang L; Zhu L; Chen C; Wu R; Ni J; Wang J Theranostics; 2024; 14(4):1683-1700. PubMed ID: 38389839 [No Abstract] [Full Text] [Related]
20. Decoding Metabolic Symbiosis between Pancreatic Cancer Cells and Cancer-Associated Fibroblasts Using Cultured Tumor Microenvironment. Nihashi Y; Song X; Yamamoto M; Setoyama D; Kida YS Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]